Risk Archives - Wiser Healthcare

Development and validation of the Vaccine Barriers Assessment Tool for identifying drivers of under-vaccination in children under five years in Australia – Jessica Kaufman et al.

Lucia Marcello2024-08-02T11:45:52+10:00COVID-19, Health literacy, Health policy, Publications, Risk|

Data on routine childhood vaccination coverage can only tell us who is under-vaccinated; it cannot explain why vaccine coverage is low. Collecting data on the reasons behind under-vaccination is necessary to implement cost-effective strategies that address key barriers and target interventions appropriately. However, no instruments [...]

Are Newer Drugs Better? An Analysis of Neonatal Pharmacological Treatments across Generations – Nai Ming Lai et al.

Lucia Marcello2024-08-02T11:33:12+10:00Big pharma, Prescribing, Publications, Randomised Control Trial (RCT), Risk|

We evaluated the relative effects of newer versus older medications for neonatal conditions and trends in margin of superiority across generations. We assessed network meta-analyses (NMAs) on neonatal pharmacological interventions identified from MEDLINE, Cochrane, and PROSPERO. Interventions were chronologically arranged based on the earliest study [...]

Understanding the roles of economy and society in the relative risks of zoonosis emergence from livestock – Stephen Hinchliffe et al.

Lucia Marcello2024-08-02T11:28:53+10:00COVID-19, One Health, Publications, Risk|

The emergence of zoonotic infections that can develop into pathogens of pandemic potential is a major concern for public health. The risks of emergence and transmission relate to multiple factors that range from land use to human–non-human animal contacts. Livestock agriculture plays a potentially significant [...]

Demonstrating the use of population level data to investigate trends in the rate, radiation dose and cost of Computed Tomography across clinical groups: Are there any areas of concern? – Sviatlana Kamarova et al.

Lucia Marcello2024-08-02T11:08:57+10:00Imaging, Low-value care, Overuse, Publications, Risk|

Increases in computed tomography (CT) use may not always reflect clinical need or improve outcomes. This study aimed to demonstrate how population level data can be used to identify variations in care between patient groups, by analysing system-level changes in CT use around the diagnosis [...]

Evaluating the STarTBack stratified treatment approach for low back pain: exploring study-level factors potentially explaining differences in results of studies – a literature review – Christopher S Han et al.

Lucia Marcello2024-07-31T11:32:31+10:00Back pain, Low back pain, Musculoskeletal, Pain, Physiotherapy, Primary Care, Publications, Randomised Control Trial (RCT), Research, Risk, Treatment|

Risk-based stratified care involves selecting treatments according to a participant's risk of persistent disabling pain, to maximise treatment benefit and reduce potential harm and wasted resources associated with unnecessary interventions. The STarTBack approach is a widely known and investigated example of a risk-based stratified care [...]

Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia – Daniel Lindsay et al.

Lucia Marcello2024-07-30T15:40:18+10:00Cancer, Melanoma, Overdiagnosis, Overtreatment, Publications, Risk|

Research suggests a high proportion of melanoma in situ (MIS) may be overdiagnosed, potentially contributing to overtreatment, patient harm and inflated costs for individuals and healthcare systems. However, Australia-wide estimates of the magnitude of melanoma overdiagnosis are potentially outdated and there has been no estimation of the [...]

Breast cancer screening from age 40 in the US – Katy JL Bell et al.

Lucia Marcello2024-07-30T11:45:58+10:00Breast cancer, Cancer, Health policy, Overdiagnosis, Publications, Risk, Screening, Women's health|

The US Preventive Services Task Force has updated its recommendation for the age when all women should start mammography screening, lowering it from 50 to 40. This change immediately affects more than 20 million American women and other people assigned female at birth who are [...]

Improving how we determine who should take blood pressure and lipid-lowering medications – Jenny Doust

Lucia Marcello2024-07-30T11:37:55+10:00Cardiovascular disease, Clinical guidelines, Hypertension, Publications, Risk, Treatment|

Cardiovascular disease (CVD) risk equations are useful to guide treatment decisions for blood pressure and lipid-lowering medications because they identify patients who are at high risk of CVD but do not have either blood pressure or cholesterol measurements above the levels when considering treatment as [...]

Facilitating public involvement in research about healthcare AI: A scoping review of empirical methods – Emma Kellie Frost et al.

Lucia Marcello2024-07-30T10:12:52+10:00AI, Publications, Research, Risk, Screening|

With the recent increase in research into public views on healthcare artificial intelligence (HCAI), the objective of this review is to examine the methods of empirical studies on public views on HCAI. We map how studies provided participants with information about HCAI, and we examine [...]

Eliminate all risks: A call to reexamine the link between canine scabies and rheumatic heart disease – Victoria J. Brookes et al.

Lucia Marcello2024-06-12T17:46:43+10:00Cardiovascular disease, One Health, Publications, Risk|

Rheumatic heart disease (RHD) and acute rheumatic fever (ARF) disproportionately affect individuals in low-resource settings. ARF is attributed to an immune response to Group A Streptococcus (GAS) following GAS pharyngitis and potentially GAS impetigo in which infection can be initiated by scabies infestation. The burden of ARF [...]

Risk

Staff Intranet